Evidence map›Paper›PMID 15634974›Full record

ArticleJournal of clinical microbiology2005

Rapid, high-throughput, multiplex, real-time PCR for identification of mutations in the cyp51A gene of Aspergillus fumigatus that confer resistance to itraconazole.

Sergey V Balashov, Rebecca Gardiner, Steven Park, David S Perlin

Open access · greenAbstract readEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 72 citations in OpenAlex.

  1. Genotype-Phenotype Relationships in Azole-ResistantJournal of fungi (Basel, Switzerland) · 2026
    Review
  2. Article
  3. Article
  4. Can We Improve Antifungal Susceptibility Testing?Frontiers in cellular and infection microbiology · 2021
    Review
  5. High-Frequency Direct Detection of Triazole Resistance inJournal of fungi (Basel, Switzerland) · 2020
    Article
  6. Detecting Azole-Antifungal Resistance inJournal of fungi (Basel, Switzerland) · 2020
    Review
  7. Article
  8. Review
  9. Review
  10. Drug Sensitivity and Resistance Mechanism in Aspergillus SectionAntimicrobial agents and chemotherapy · 2017
    Article
  11. Review
  12. Article
  13. Regulatory circuitry governing fungal development, drug resistance, and disease.Microbiology and molecular biology reviews : MMBR · 2011
    Review
  14. High-frequency triazole resistance found In nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2011
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Sergey V BalashovPublic Health Research Institute, International Center for Public Health, 225 Warren St., Newark, NJ 07103, USA.
Rebecca Gardiner
Steven Park
David S Perlin
International Center for Public Health · US

Funding

Rapid Evaluation of Drug Resistance in Pathogenic FungiR21AI055767 · NIAID · PUBLIC HEALTH RESEARCH INSTITUTE · PI PERLIN, DAVID S · 2003 to 2004
$485k
NIAID NIH HHS AI055767NIAID NIH HHS R21 AI055767
6 · The paper itself

Abstract

Aspergillus fumigatus is an important cause of life-threatening invasive fungal disease in patients with compromised immune systems. Resistance to itraconazole in A. fumigatus is closely linked to amino acid substitutions in Cyp51A that replace Gly54. In an effort to develop a new class of molecular diagnostic assay that can rapidly assess drug resistance, a multiplexed assay was established. This assay uses molecular beacons corresponding to the wild-type cyp51A gene and seven mutant alleles encoding either Arg54, Lys54, Val54, Trp54, or Glu54. Molecular beacon structure design and real-time PCR conditions were optimized to increase the assay specificity. The multiplex assay was applied to the analysis of chromosomal DNA samples from a collection of 48 A. fumigatus clinical and laboratory-derived isolates, most with reduced susceptibility to itraconazole. The cyp51A allelic identities for codon 54 were established for all of the strains tested, and mutations altering Gly54 in 23 strains were revealed. These mutations included G(54)W (n = 1), G(54)E (n = 12), G(54)K (n = 3), G(54)R (n = 3), and G(54)V (n = 4). Molecular beacon assay results were confirmed by DNA sequencing. Multiplex real-time PCR with molecular beacons is a powerful technique for allele differentiation and analysis of resistance mutations that is dynamic and suitable for rapid high-throughput assessment of drug resistance.

Indexed as

Antifungal AgentsAspergillus fumigatusCytochrome P-450 Enzyme SystemDNA, FungalDrug Resistance, FungalFungal ProteinsHumansItraconazoleMicrobial Sensitivity TestsMolecular ProbesMutationPolymerase Chain ReactionTime FactorsAntifungal Agentscytochrome P-450 CYP51A, AspergillusCytochrome P-450 Enzyme SystemDNA, FungalFungal ProteinsItraconazoleMolecular Probes

Identifiers

PMID15634974
PMCPMC540178
OpenAlexW2089167891

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.